GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicamen Organics Ltd (NSE:MEDIORG) » Definitions » Cash, Cash Equivalents, Marketable Securities

Medicamen Organics (NSE:MEDIORG) Cash, Cash Equivalents, Marketable Securities : ₹5.5 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Medicamen Organics Cash, Cash Equivalents, Marketable Securities?

Medicamen Organics's quarterly cash, cash equivalents, marketable securities declined from Mar. 2023 (₹5.28 Mil) to Sep. 2023 (₹5.03 Mil) but then increased from Sep. 2023 (₹5.03 Mil) to Mar. 2024 (₹5.53 Mil).

Medicamen Organics's annual cash, cash equivalents, marketable securities increased from Mar. 2022 (₹4.37 Mil) to Mar. 2023 (₹5.28 Mil) and increased from Mar. 2023 (₹5.28 Mil) to Mar. 2024 (₹5.53 Mil).


Medicamen Organics Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Medicamen Organics's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicamen Organics Cash, Cash Equivalents, Marketable Securities Chart

Medicamen Organics Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Cash, Cash Equivalents, Marketable Securities
8.82 4.37 5.28 5.53

Medicamen Organics Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24
Cash, Cash Equivalents, Marketable Securities 8.82 4.37 5.28 5.03 5.53

Medicamen Organics Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Medicamen Organics  (NSE:MEDIORG) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Medicamen Organics Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Medicamen Organics's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicamen Organics Business Description

Industry
Traded in Other Exchanges
N/A
Address
Ashok Vihar Phase II, 10, Community Center No. 2, New Delhi, IND, 110052
Medicamen Organics Ltd is engaged in developing, manufacturing, and distribution of broad range of pharmaceutical dosages including generic dosages in the form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government and private institutions as contract manufacturer/third party manufacturer. The company markets its product to private pharma companies in domestic as well as international markets through third-party distributors or on a loan license basis.

Medicamen Organics Headlines

No Headlines